Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 14/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.58 |
| ▸ | HRH2 | P25021 | 2/20 | 0.54 |
| ▸ | HRH1 | P35367 | 2/20 | 0.54 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3586381 | 0.94 | HRH3 (0.66) | HRH3KCNH2HRH2HRH1AKR1C3 | |
| SCHEMBL3581097 | 0.91 | HRH3 (0.64) | HRH3KCNH2HRH2HRH1MAPT | |
| SCHEMBL3577263 | 0.81 | HRH3 (0.65) | HRH3KCNH2HRH1 | |
| SCHEMBL6472573 | 0.80 | HRH3 (0.72) | HRH3KCNH2HRH1MAPTALDH1A1 | |
| SCHEMBL3585275 | 0.80 | HRH3 (0.62) | HRH3KCNH2HRH2HRH1MAPT | |
| SCHEMBL13437926 | 0.80 | HRH3 (0.81) | HRH3KCNH2HRH2HRH1MAPT | |
| SCHEMBL3573919 | 0.80 | HRH3 (0.81) | HRH3KCNH2HRH2HRH1MAPT | |
| SCHEMBL3584179 | 0.80 | HRH3 (0.81) | HRH3KCNH2HRH2HRH1MAPT | |
| SCHEMBL3586173 | 0.79 | HRH3 (0.71) | HRH3KCNH2HRH1MAPTALDH1A1 | |
| SCHEMBL3575356 | 0.79 | HRH3 (0.54) | HRH3KCNH2HRH2HRH1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1567511-A1 | SUBSTITUTED PIPERAZINES, (1,4) DIASZEPINES, AND 2,5-DIAZABICYCLO (2.2.1) HEPTANES AS HISTAMINE H1 AND/OR H3 ANTAGONISTS OR HISTAMINE H3 REVERSE ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2005-08-31 | — | — | EP | disclosed |
| WO-2004035556-A1 | SUBSTITUTED PIPERAZINES, (1,4) DIASZEPINES, AND 2,5-DIAZABICYCLO (2.2.1) HEPTANES AS HISTAMINE H1 AND/OR H3 ANTAGONISTS OR HISTAMINE H3 REVERSE ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2004-04-29 | — | — | WO | disclosed |